Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Boehringer Ingelheim
Cipla
Fish and Richardson
Federal Trade Commission
Colorcon
Covington
Accenture
Fuji

Generated: August 17, 2017

DrugPatentWatch Database Preview

AXOTAL Drug Profile

« Back to Dashboard

What is the patent landscape for Axotal, and what generic Axotal alternatives are available?

Axotal is a drug marketed by Savage Labs and is included in one NDA.

The generic ingredient in AXOTAL is aspirin; butalbital. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; butalbital profile page.

Summary for Tradename: AXOTAL

Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AXOTAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs
AXOTAL
aspirin; butalbital
TABLET;ORAL088305-001Oct 13, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Medtronic
Julphar
Cerilliant
Moodys
QuintilesIMS
Colorcon
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot